Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection

<p><strong>Background</strong> A synergistic effect of combination therapy with favipiravir and oseltamivir has been reported in preclinical models of influenza. However, no data are available on the clinical effectiveness of combination therapy in severe influenza.</p> <...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Wang, Y, Fan, G, Salam, A, Horby, P, Hayden, F, Chen, C, Pan, J, Zheng, J, Lu, B, Guo, L, Wang, C, Cao, B, Cap-China Network
Format:	Journal article
Język:	English
Wydane:	Oxford University Press 2019

Podobne zapisy

Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza
od: Wang, Y, i wsp.
Wydane: (2020)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
od: Parvaiz A Koul, i wsp.
Wydane: (2024-01-01)

Does Oseltamivir Really Reduce Complications of Influenza?
od: Del Mar, C, i wsp.
Wydane: (2011)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
od: Chairat, K, i wsp.
Wydane: (2016)

Monitoring the sensitivity of influenza viruses to oseltamivir, in Romania, from 2016 to 2023
od: Mihai Maria Elena, i wsp.
Wydane: (2024-04-01)

Ode to Oseltamivir and Amantadine?
od: JM Conly, i wsp.
Wydane: (2006-01-01)

Exacerbation of neuropsychiatric symptoms in an adult male with influenza A virus treated with oseltamivir
od: Masa Scott, PharmD, BCPS, BCPP, i wsp.
Wydane: (2024-12-01)

Impact of Oseltamivir and Diabetes Development
od: Bor-Show Tzang, i wsp.
Wydane: (2025-01-01)

Oseltamivir and influenza-related complications in children: a retrospective cohort in primary care
od: Lee, J, i wsp.
Wydane: (2020)

Evaluation of the efficacy of triazavirin versus oseltamivir in management of COVID-19
od: Sara Samir Mohamed Elmenshawy, i wsp.
Wydane: (2024-12-01)

Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.
od: Anthony C Marriott, i wsp.
Wydane: (2014-01-01)

Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States
od: Svenn Alexander Kommandantvold, i wsp.
Wydane: (2024-08-01)

Acute Cheilitis Associated with Oseltamivir after Influenzae A Infection
od: Koji Yokoyama, i wsp.
Wydane: (2023-01-01)

Impact of oseltamivir on the risk of cancer
od: Pei-Hua Chuang, i wsp.
Wydane: (2024-02-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
od: A.B. Ivanyuk, i wsp.
Wydane: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
od: A.B. Ivanyuk, i wsp.
Wydane: (2008-01-01)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
od: Instiaty, I, i wsp.
Wydane: (2013)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
od: Seo, S, i wsp.
Wydane: (2013)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza.
od: Le, Q, i wsp.
Wydane: (2010)

A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza
od: Mai, L, i wsp.
Wydane: (2010)

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial
od: Butler, CC, i wsp.
Wydane: (2019)

Oseltamivir resistance in influenza A (H5N1) infection - Reply
od: Jong, d, i wsp.
Wydane: (2006)

Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model.
od: Hurt, A, i wsp.
Wydane: (2010)

Ergoferon and Oseltamivir in Treatment of Influenza: Results of Multicentre Randomized Comparative Clinical Trial
od: A. V. Averyanov, i wsp.
Wydane: (2020-05-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
od: A.S. Kolbin, i wsp.
Wydane: (2008-11-01)

OSELTAMIVIR IN PEDIATRIC PRACTICES (WORLD'S APPLICATION EXPERIENCE)
od: A.S. Kolbin, i wsp.
Wydane: (2008-11-01)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
od: Wattanagoon, Y, i wsp.
Wydane: (2009)

Efficacy and safety of intravenous peramivir versus oral oseltamivir in the treatment of influenza in children: A meta-analysis
od: Jie Yuan, i wsp.
Wydane: (2024-06-01)

Effectiveness of Antiviral Treatment with Intravenous Peramivir and Oral Oseltamivir for Seasonal Influenza in Children
od: Young-hoon Byun, i wsp.
Wydane: (2024-12-01)

Evaluation of the Efficacy of Riamilovir and Oseltamivir Combination on the Experimental Model of Mice Influenza Infection
od: I. N. Falynskova, i wsp.
Wydane: (2020-05-01)

Oseltamivir resistance during treatment of influenza A (H5N1) infection.
od: Jong, d, i wsp.
Wydane: (2005)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
od: A.S. Darmanyan
Wydane: (2007-10-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
od: T.V. Kulichenko, i wsp.
Wydane: (2007-12-01)

OSELTAMIVIR IN FLU TREATMENT AND PREVENTION AMONG CHILDREN
od: T.V. Kulichenko, i wsp.
Wydane: (2007-12-01)

EFFICIENCY AND SAFETY OF NEURAMINIDASE INHIBITOR OSELTAMIVIR FOR CHILDREN
od: A.S. Darmanyan
Wydane: (2007-10-01)

Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir
od: Wouter J. Meijer, i wsp.
Wydane: (2015-01-01)

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.
od: Jefferson, T, i wsp.
Wydane: (2014)

Importance of collection tube during clinical studies of oseltamivir.
od: Lindegardh, N, i wsp.
Wydane: (2007)

Prescription of Antibiotics Among Patients Receiving Oseltamivir with an Influenza Related Diagnosis Over Three Influenza Seasons
od: Mine Durusu Tanriover, i wsp.
Wydane: (2024-12-01)

Epidemiological, clinical characteristics and the association between influenza vaccination, oseltamivir treatment, and complications in children with seasonal influenza
od: Manh Cuong Nguyen, i wsp.
Wydane: (2024-06-01)